TGFβ Signaling and Cardiovascular Diseases

被引：2

作者：

Pardali, Evangelia ^{[1
]}

ten Dijke, Peter ^{[2
,3
]}

机构：

[1] Univ Hosp Munster, Dept Cardiol & Angiol, Munster, Germany

[2] Leiden Univ, Med Ctr, Ctr Biomed Genet, Leiden, Netherlands

[3] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands

来源：

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES | 2012年 / 8卷 / 02期

关键词：

atherosclerosis; BMP; hypertension; Smad; TGF beta; vessel calcification; TRANSFORMING-GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; BONE MORPHOGENETIC PROTEIN; HEREDITARY HEMORRHAGIC TELANGIECTASIA; PULMONARY ARTERIAL-HYPERTENSION; NITRIC-OXIDE SYNTHASE; HUMAN ATHEROSCLEROTIC LESIONS; VASCULAR ENDOTHELIAL-CELLS; AORTIC-ANEURYSM PROGRESSION; RECEPTOR-LIKE KINASE-1;

D O I：

10.7150/ijbs.8.195

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Transforming growth factor beta (TGF beta) family members are involved in a wide range of diverse functions and play key roles in embryogenesis, development and tissue homeostasis. Perturbation of TGF beta signaling may lead to vascular and other diseases. In vitro studies have provided evidence that TGF beta family members have a wide range of diverse effects on vascular cells, which are highly dependent on cellular context. Consistent with these observations genetic studies in mice and humans showed that TGF beta family members have ambiguous effects on the function of the cardiovascular system. In this review we discuss the recent advances on TGF beta signaling in (cardio) vascular diseases, and describe the value of TGF beta signaling as both a disease marker and therapeutic target for (cardio) vascular diseases.

引用

页码：195 / 213

页数：19

共 50 条

[1] TGFβ Signaling Pathways and Human Diseases
Richard W. Padgett
Cancer and Metastasis Reviews, 1999, 18 : 247 - 259
[2] TGFβ signaling pathways and human diseases
Padgett, RW
CANCER AND METASTASIS REVIEWS, 1999, 18 (02) : 247 - 259
[3] TGF-β Signaling in Control of Cardiovascular Function
Goumans, Marie-Jose
ten Dijke, Peter
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2018, 10 (02):
[4] The Roles of TGF-β Signaling in Cerebrovascular Diseases
Zhang, Yizhe
Yang, Xiao
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
[5] Regulation of TGF-β signaling and vascular diseases
Miyazono, K.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 718 - 718
[6] Involvement of purinergic signaling in cardiovascular diseases
Ralevic, V
Burnstock, G
DRUG NEWS & PERSPECTIVES, 2003, 16 (03) : 133 - 140
[7] Ceramide in Redox Signaling and Cardiovascular Diseases
Li, Xiang
Becker, Katrin Anne
Zhang, Yang
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2010, 26 (01) : 41 - 48
[8] Sphingolipid metabolism and signaling in cardiovascular diseases
Borodzicz-Jazdzyk, Sonia
Jazdzyk, Piotr
Lysik, Wojciech
Cudnoch-Jedrzejewska, Agnieszka
Czarzasta, Katarzyna
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
[9] Overnutrition, mTOR signaling, and cardiovascular diseases
Jia, Guanghong
Aroor, Annayya R.
Martinez-Lemus, Luis A.
Sowers, James R.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2014, 307 (10) : R1198 - R1206
[10] Epigenetic Signaling and RNA Regulation in Cardiovascular Diseases
Mongelli, Alessia
Atlante, Sandra
Bachetti, Tiziana
Martelli, Fabio
Farsetti, Antonella
Gaetano, Carlo
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (02)

← 1 2 3 4 5 →